HSPB8-related autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome

Muscle weakness typically presents as difficulty in performing tasks that require strength, such as climbing stairs or lifting objects. It is caused by the degeneration of motor neurons and muscle fibers due to the accumulation of abnormal proteins. Over time, the weakness may progress from distal to proximal muscles, affecting larger muscle groups. This symptom significantly impacts daily life, often requiring physical therapy and assistive devices to maintain mobility and independence.

Muscle atrophy manifests as a noticeable decrease in muscle size and bulk, often accompanied by weakness. It results from the loss of muscle fibers due to ongoing degeneration and insufficient regeneration. As the condition progresses, atrophy can lead to significant functional impairment and disability. Patients may benefit from physical therapy and nutritional support to slow the progression and maintain muscle mass.

Muscle cramps are sudden, involuntary contractions of muscles, often causing significant pain and discomfort. They occur due to the instability of muscle fibers and altered nerve signaling. Over time, cramps may become more frequent and severe, disrupting sleep and daily activities. Management includes stretching exercises, hydration, and medications to alleviate symptoms.

Fatigue is a persistent feeling of tiredness or exhaustion that is not relieved by rest. It is caused by the increased energy expenditure required to perform daily tasks due to muscle weakness and inefficiency. Over time, fatigue can worsen, leading to decreased participation in social and occupational activities. Management strategies include energy conservation techniques and optimizing sleep quality.

Gait abnormalities present as an altered walking pattern, often characterized by a steppage gait or foot drop. These abnormalities result from weakness in the distal muscles of the legs, affecting the ability to lift the foot properly. As the condition progresses, walking may become increasingly difficult, increasing the risk of falls. Physical therapy and orthotic devices can help improve gait and prevent complications.

Sensory disturbances include numbness, tingling, or a 'pins and needles' sensation, primarily in the extremities. These symptoms arise from the involvement of sensory nerves, although motor symptoms are more prominent. Over time, sensory disturbances can lead to difficulties with balance and coordination. Management may involve medications to alleviate discomfort and strategies to enhance safety and function.

Respiratory difficulties may manifest as shortness of breath or reduced exercise tolerance. These issues occur due to weakness of the respiratory muscles, which can compromise effective breathing. As the condition advances, respiratory function may decline, necessitating interventions such as respiratory therapy or mechanical ventilation. Early recognition and management are crucial to prevent severe complications.

Cardiac involvement can present as arrhythmias or cardiomyopathy, affecting the heart's ability to pump effectively. This occurs due to the deposition of abnormal proteins in cardiac tissue, similar to skeletal muscle involvement. Over time, cardiac symptoms can lead to heart failure or other serious complications. Regular cardiac monitoring and appropriate medical management are essential to address these issues.

The clinician looks for signs of distal muscle weakness, atrophy, and sensory loss, particularly in the lower limbs. A detailed family history is crucial to identify any hereditary patterns of neuromuscular disorders. Physical examination may reveal muscle wasting, decreased reflexes, and gait abnormalities. This step helps differentiate between neuropathic and myopathic processes and guides further testing.

Magnetic Resonance Imaging (MRI) of the muscles is commonly used to assess muscle integrity and detect fatty infiltration or atrophy. Specific abnormalities such as selective muscle involvement can be visible, which supports the diagnosis of a myopathic process. MRI findings help confirm the diagnosis by showing patterns consistent with myofibrillar myopathy. Imaging also helps exclude other conditions such as central nervous system lesions or structural abnormalities.

Creatine kinase (CK) levels are often measured, as elevated levels can indicate muscle damage. Biomarkers such as lactate and pyruvate may be assessed to rule out mitochondrial disorders. Abnormal results typically show elevated CK levels, supporting a diagnosis of myopathy. These results guide the clinician to pursue genetic testing for definitive diagnosis.

Genetic testing involves sequencing the HSPB8 gene to identify pathogenic mutations. Mutations such as missense or nonsense variants are typically found in affected individuals. The presence of a pathogenic mutation in HSPB8 confirms the diagnosis of this syndrome. Genetic results are crucial for family counseling and assessing the risk of transmission to offspring.